Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
Patents for C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
07/2013
07/25/2013US20130190497 Fluorescent substrates for monoamine transporters as optical false neurotransmitters
07/24/2013EP2617712A1 Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using same
07/24/2013EP2616444A2 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
07/24/2013CN101792422B Novel organic electroluminescent compounds and organic electroluminescent device using the same
07/11/2013WO2013102249A1 N-phenylpiperazine derivatives that are antagonists of α1a, α1d adrenoceptors and 5-ht1a receptors for the treatment of benign prostate hyperplasia, pharmaceutical compositions containing the same
07/11/2013US20130178494 Phenyl n-mustard linked to dna-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents
07/10/2013CN103193707A Method for preparing 9-aryl multi-hydrogen acridine ramification through catalysis
06/2013
06/27/2013WO2013093019A1 Acridinedione derivatives for treating pigmentation disorders and ageing of the skin
06/27/2013WO2013091052A1 Molecular compound comprising an acridine molecule chemically linked to a carboxylic group, which can be used for the selective destruction of solid tumour cells
06/26/2013EP2606032A2 Composition and methods for treating glioblastoma
06/26/2013CN103180297A Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators
06/25/2013US8470842 Hydrochloride salts of 8-[{1-(3,5-Bis-trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
06/20/2013WO2013089460A1 Novel chemical compound having an acridine structure, and organic light-emitting diode using same
06/20/2013US20130158065 1,2,3,4,5,6,7,8-octohydro-9-phenylacetamidoacridine, the preparation method and medical use thereof
06/13/2013US20130150254 Reagents and methods for direct labeling of nucleotides
06/12/2013CN101671291B Organic electroluminescent compounds and organic electroluminescent device using the same
06/11/2013CA2683826C Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
05/2013
05/30/2013US20130137694 Novel modulators of nrf2 and uses thereof
05/29/2013CN102146056B N-benzyl-acridone, derivatives of N-benzyl-acridone and preparation methods and application of N-benzyl-acridone and derivatives
05/14/2013US8440835 Environmentally sensitive fluorophores
04/2013
04/25/2013US20130102631 Novel microbiocidal dioxime ether derivatives
04/25/2013US20130102627 Acridines As Inhibitors Of Haspin And DYRK Kinases
04/25/2013US20130101684 Compounds, Compositions, And Methods For Reducing Or Eliminating Bitter Taste
04/17/2013CN103044582A Polymerizable acridone photoinitiator and preparation method thereof
04/16/2013US8420661 Arylethynyl derivatives
04/11/2013WO2013026866A3 Pyridine-, pyrazine-, triazine- and tetrazine-derived microbiocides
04/10/2013EP2578572A1 Compounds with acridan ring structures and organic electroluminescence elements
04/10/2013CN103030596A Dihydracridine material and application thereof
04/09/2013CA2704986C Use of an ionic compound, derived from malononitrile as a photoinitiator, radical initiators or catalyser in polymerization processes or as a basic dye
03/2013
03/28/2013WO2013044123A1 Uses of bis(3)-cognitin and related compounds
03/28/2013US20130075715 Compound having acridan ring structure, and organic electroluminescent device
03/27/2013CN101370783B Salts of 1-alkylamino-1-desoxypolyols with 9-oxoacridine-10-acetic acid, medicinal preparations on base, use, preventive measures and treatment thereof
03/26/2013US8404702 Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
03/26/2013US8404681 Xanthones, thioxanthones and acridinones as DNA-PK inhibitors
03/07/2013WO2013033430A1 Targeted delivery and prodrug designs for platinum-acridine anti-cancer compounds and methods thereof
03/06/2013CN102952071A Ultraviolet curing monomer and preparation method thereof, polymerizable composition and backlight module
02/2013
02/27/2013CN102942566A Dimeric and trimeric nucleic acid dyes, and associated systems and methods
02/13/2013CN102933552A Compound having acridan ring structure, and organic electroluminescent device
02/13/2013CN102924431A Organic luminescent compound containing acridine core and application thereof in electroluminescent device
02/13/2013CN102924217A Fluorene and pyrene derivatives and organic electroluminescent device using the same
02/13/2013CN102219740B 1,2,3,4,5,6,7,8-octahydro-9-phenylacetamide acridine as well as preparation method and medicinal application thereof
02/07/2013US20130035351 Oximes For Treatment Of Peripheral And Central Nervous System Exposure To Acetyl Cholinesterase Inhibitors
01/2013
01/29/2013US8361500 Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom
01/24/2013WO2013011954A1 Organic electroluminescence element and compound used therein
01/24/2013US20130023521 Novel selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications
01/17/2013US20130018180 Crystals of human topoisomerase ii-dna binary complex, methods for preparing the same and uses thereof
12/2012
12/18/2012US8334316 Substituted organosulfur compounds and methods of using thereof
12/05/2012CN102812004A Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using the same
12/05/2012CN101857548B Two-aromatic amino terminated dianthracene compound, preparation method and application thereof
11/2012
11/21/2012EP2523938A1 Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
11/21/2012CN102786471A Preparation method of ethacridine lactate intermediate
11/14/2012CN102781919A Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
11/01/2012WO2012147330A1 Compound with acridan ring structure, and organic electroluminescent element
10/2012
10/31/2012CN102762539A Zwitterion-containing acridinium compounds
10/24/2012CN102746226A Acridine derivative and preparation method and application thereof
10/23/2012US8293908 Facile N-alkylation of acridine compounds in ionic liquids
10/23/2012CA2523178C Materials and methods to potentiate cancer treatment
10/18/2012WO2012141249A1 Organic electroluminescent element
10/17/2012EP2509953A2 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators
10/11/2012WO2012137741A1 Method for purifying organic material, material for organic electronics, photoelectric conversion element, optical sensor, imaging element, and organic electroluminescent element
10/11/2012US20120259098 Dendrimer compositions and methods of synthesis
10/02/2012US8278326 Inhibitors of protein phosphatase-1 and uses thereof
09/2012
09/26/2012EP2502915A1 Aromatic sulfonium salt compound
09/26/2012EP2501681A1 Zwitterion-containing acridinium compounds
09/26/2012CN102690244A Substances regulating alpha-synuclein accumulation and its pharmaceutical application
09/19/2012CN102675206A Preparation method of novel acetylcholinesterase inhibitor, and activity thereof
09/19/2012CN102675203A Preparation method of acridine compounds
09/13/2012US20120231459 Chemiluminescent probes for multiplex molecular quantification and uses thereof
09/05/2012EP2493857A1 9-aminoacridine derivatives, their preparation and uses
09/05/2012CN101528685B New benzamide derivatives as bradykinin antagonists
08/2012
08/30/2012US20120220537 9-aminoacridine derivatives, their preparation and uses
08/16/2012WO2012036573A3 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
08/14/2012US8242115 Materials and methods to potentiate cancer treatment
08/08/2012EP2074101B1 Stable acridinium esters with fast light emission
08/01/2012CN102617465A Tacrine-caffeic acid hetero-blends, their preparation method and medicinal compositions
07/2012
07/25/2012EP2479160A1 Process for production of oxidation reaction product of aromatic compound
07/24/2012US8227480 Indazole derivative having spiro ring structure in side chain
07/10/2012CA2536658C Chemiluminescent compounds
07/05/2012US20120168730 Acridine derivative and organic electroluminescence device including the same
07/04/2012CN1248245B Frangible compounds for pathogen inactivation
07/04/2012CN102548968A Aromatic heterocyclic derivative, and organic electroluminescent element comprising same
07/04/2012CN101898982B Npy y5 antagonists
06/2012
06/20/2012CN102510856A 芳香族锍盐化合物 The aromatic sulfonium salt compound
06/13/2012CN102498084A Process for production of oxidation reaction product of aromatic compound
05/2012
05/31/2012US20120136155 Aromatic sulfonium salt compound
05/23/2012CN101914060B Synthesis of polyhydroacridine derivatives by clean catalysis of degradable ionic liquid
05/18/2012WO2012028167A3 Acridinium ester chemiluminescence upon reductive triggering
05/15/2012US8178550 Hydrochloride salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy)-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
05/08/2012US8173274 Organic compound and organic electroluminescence device employing the same
04/2012
04/26/2012WO2012024670A3 Composition and methods for treating glioblastoma
04/25/2012EP2443462A1 Methods for detecting the presence or absence of blood
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/19/2012WO2012049828A1 Aromatic heterocyclic derivative, and organic electroluminescent element comprising same
04/17/2012CA2667387C New benzamide derivatives as bradykinin antagonists
04/17/2012CA2371625C Polyamines and their use in therapy
04/11/2012EP1539702B1 Hydrophilic chemiluminescent acridinium labeling reagents
03/2012
03/28/2012CN102391180A Sulfydryl-containing tacrine derivative and preparation method and application thereof
03/22/2012WO2012036573A2 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
03/22/2012US20120071502 Novel phenoxyisobutyric acid compounds and methods for synthesis
03/22/2012CA2811265A1 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
1 2 3 4 5 6 7 8 9 10 11 12 ... 22